These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1548888)

  • 1. Urinary gonadotropin fragment measurements in patients with lung and esophageal disease.
    D'Agostino RS; Cole LA; Ponn RB; Stern H; Schwartz PE
    J Surg Oncol; 1992 Mar; 49(3):147-50. PubMed ID: 1548888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary gonadotropin fragment, a new tumor marker. I. Assay development and cancer specificity.
    Nam JH; Cole LA; Chambers JT; Schwartz PE
    Gynecol Oncol; 1990 Mar; 36(3):383-90. PubMed ID: 2318449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
    Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
    Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary gonadotropin fragment (UGF) measurements in the diagnosis and management of ovarian cancer.
    Cole LA; Nam JH
    Yale J Biol Med; 1989; 62(4):367-78. PubMed ID: 2596125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary gonadotropin fragment, a new tumor marker. II. Differentiating a benign from a malignant pelvic mass.
    Cole LA; Nam JH; Chambers JT; Schwartz PE
    Gynecol Oncol; 1990 Mar; 36(3):391-4. PubMed ID: 2318450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of urinary beta-core fragment of human chorionic gonadotropin as a new tumor marker of lung cancer.
    Yoshimura M; Nishimura R; Murotani A; Miyamoto Y; Nakagawa T; Hasegawa K; Koizumi T; Shii K; Baba S; Tsubota N
    Cancer; 1994 Jun; 73(11):2745-52. PubMed ID: 7514953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. I. Sensitivity and specificity, comparison with other markers.
    Cole LA; Schwartz PE; Wang YX
    Gynecol Oncol; 1988 Sep; 31(1):82-90. PubMed ID: 3044936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of urinary beta core fragment of human chorionic gonadotrophin in women with vulvovaginal malignancy and its prognostic significance.
    Carter PG; Iles RK; Neven P; Ind TE; Shepherd JH; Chard T
    Br J Cancer; 1995 Feb; 71(2):350-3. PubMed ID: 7530986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary gonadotropin fragment, a new tumor marker. III. Use in cervical and vulvar cancers.
    Nam JH; Chang KC; Chambers JT; Schwartz PE; Cole LA
    Gynecol Oncol; 1990 Jul; 38(1):66-70. PubMed ID: 2354828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The origin of a human chorionic gonadotropin beta-subunit-core fragment excreted in the urine of patients with cancer.
    Papapetrou PD; Nicopoulou SC
    Acta Endocrinol (Copenh); 1986 Jul; 112(3):415-22. PubMed ID: 2428192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary chorionic gonadotropin subunits and beta-core in nonpregnant women. A study of benign and malignant gynecologic disorders.
    Neven P; Iles RK; Lee CL; Hudson CN; Shepherd JH; Chard T
    Cancer; 1993 Jun; 71(12):4124-30. PubMed ID: 7685240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta human chorionic gonadotrophin in serum and urine. A marker for metastatic urothelial cancer.
    Iles RK; Jenkins BJ; Oliver RT; Blandy JP; Chard T
    Br J Urol; 1989 Sep; 64(3):241-4. PubMed ID: 2478247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary gonadotropin fragment, a new tumor marker. IV. Use in endometrial cancers and uterine mixed mullerian tumors.
    Nam JH; Chambers JT; Schwartz PE; Cole LA
    Gynecol Oncol; 1990 Dec; 39(3):352-7. PubMed ID: 2175287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urinary gonadotropin fragment measurement in the monitoring of trophoblastic disease].
    Fu CY; Cole LA; Kardana A
    Zhonghua Fu Chan Ke Za Zhi; 1994 Aug; 29(8):475-7, 510-1. PubMed ID: 7835119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies.
    O'Connor JF; Schlatterer JP; Birken S; Krichevsky A; Armstrong EG; McMahon D; Canfield RE
    Cancer Res; 1988 Mar; 48(5):1361-6. PubMed ID: 2449279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. II. Initial serial studies.
    Wang YX; Schwartz PE; Chambers JT; Cole LA
    Gynecol Oncol; 1988 Sep; 31(1):91-102. PubMed ID: 3410359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment.
    Badgwell D; Lu Z; Cole L; Fritsche H; Atkinson EN; Somers E; Allard J; Moore RG; Lu KH; Bast RC
    Gynecol Oncol; 2007 Sep; 106(3):490-7. PubMed ID: 17532030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-core fragment (beta-core/UGF/UGP), a tumor marker: a 7-year report.
    Cole LA; Tanaka A; Kim GS; Park SY; Koh MW; Schwartz PE; Chambers JT; Nam JH
    Gynecol Oncol; 1996 Feb; 60(2):264-70. PubMed ID: 8631549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved methods for detecting beta-core in normal and cancer patient urines.
    Tanaka A; Cole LA
    Clin Chem; 1994 Dec; 40(12):2317-8. PubMed ID: 7988019
    [No Abstract]   [Full Text] [Related]  

  • 20. Choriocarcinoma mimicry of an esophageal carcinoma with urinary gonadotropic activities.
    Sasano N; Abe S; Satake O; Endo K; Sato M
    Tohoku J Exp Med; 1970 Feb; 100(2):153-63. PubMed ID: 5443625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.